Multidistrict Litigation Cases

2:11-md-02226-DCR - Orders

Practice and Procedures Order Schedule A - Initial Case List Schedule B - Initial Service List Case Management and Scheduling Order No. 1 Order Appointing Counsel to Leadership Positions Case Management and Scheduling Order No. 2 Show Cause Order Case Management Scheduling Order No.3 Order Re: Appointment of Plaintiffs' Liaison Counsel Sanctions Order Show Cause Order 2 Order Outlining Terms of Common Benefit Fund Show Cause Order 3 Show Cause Order 4 Memorandum, Opinion & Order re: Xanodyne Pharmaceuticals, Inc.'s Motions to Dismiss Memorandum, Opinion & Order re: Generic Defendents Motion to Dismiss Memorandum, Opinion & Order re: Eli Lilly Motion to Dismiss and Judgment on Pleadings Case Management and Scheduling Order No. 4 Order Directing Plaintiffs to Show Cause why claims as to Generic Defendants should not be Dismissed Memorandum Opinion and Order granting Defendant Endo Pharmaceuticals Holdings, Inc.'s and Defendant Endo Pharmaceuticals, Inc.'s Motion to Dismiss Order Directing Plaintiffs to Show Cause Why Claims as to Generic Defendants Should not be Dismissed Agreed Order Re Eli Lilly and Company's Dispositive Motions in Cases in which Plaintiffs have not Amended Their Pleadings Procedures Governing Discovery Document Production Protocol and Cost of Production Order Case List Service List

---